AXIM BIOTECHNOLOGIES, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-6.3M | $2.1M |
| FY2018 | — | $-6.1M | $1.8M |
| FY2019 | — | $-6.8M | $511.6K |
| FY2020 | — | $1.6M | $457.2K |
| FY2021 | — | $-2.3M | $453.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-6.3M | $2.1M |
| FY2018 | — | $-6.1M | $1.8M |
| FY2019 | — | $-6.8M | $511.6K |
| FY2020 | — | $1.6M | $457.2K |
| FY2021 | — | $-2.3M | $453.0K |